Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net loss from continuing operations $ (3,646,548) $ (26,212,371)
Adjustments to reconcile net loss to net cash (used in) provided by operations:    
Depreciation and amortization 345,798 409,822
Stock-based compensation 17,300
Amortization of debt discount 63,695 5,003,653
Modification of warrants 9,464,991
Gain from legal settlements (1,230,522)
HHS Provider Relief Funds (7,483,830)
Penalty for non-payment of debenture 595,440
Change in fair value of derivative instruments 105,076
Loss on sales of accounts receivable 249,500 656,949
Bargain purchase gain for hospital and medical center (250,000)
Loss from discontinued operations (23,602) (653,860)
Changes in operating assets and liabilities:    
Accounts receivable 1,328,369 (2,114,913)
Inventory (75,732) 35,292
Prepaid expenses and other current assets (16,935) (33,353)
Security deposits 9,872 39,227
Accounts payable and checks issued in excess of bank balance (1,771,184) 4,111,576
Accrued expenses 4,420,816 3,290,128
Income tax assets and liabilities (1,118,485) (45,000)
Net cash used in operating activities of continuing operations (8,948,788) (5,580,043)
Net cash (used in) provided by operating activities of discontinued operations (122,991) 153,483
Net cash used in operating activities (9,071,779) (5,426,560)
Cash flows from investing activities:    
Purchase of hospital and medical center (658,537)
Purchase of property and equipment (10,435) (43,715)
Net cash used in investing activities of continuing operations (10,435) (702,252)
Net cash from investing activities of discontinued operations
Net cash used in investing activities (10,435) (702,252)
Cash flows from financing activities:    
Proceeds from issuance of related party note payable and advances 4,595,553 9,099,126
Payments on related party note payable and advances (3,251,387) (1,510,000)
Proceeds from issuance of debentures 3,845,000
Proceeds from note payable 1,077,116
Payments on notes payable (793,715) (5,005,513)
Payments on debentures (720,000)
Proceeds from sales of accounts receivable 465,000 1,179,500
Payments on right-to-use liabilities (133,807) (92,550)
Proceeds from Paycheck Protection Program notes payable 2,368,100
HHS Provider Relief Funds 7,483,830
Payments of accounts receivable sold under sales agreements (1,073,854) (818,381)
Payments on finance lease obligations (100,707) (143,926)
Net cash provided by financing activities of continuing operations 9,916,129 6,553,256
Net cash used in financing activities of discontinued operations (40,000)
Net cash provided by financing activities 9,876,129 6,553,256
Net increase in cash 793,915 424,444
Cash at beginning of period 16,933 6,870
Cash at end of period $ 810,848 $ 431,314